Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Drugs
Volym	81
Nummer	14
Sidor (från-till)	1599 – 1604
Antal sidor	6
ISSN	0012-6667
DOI	https://doi.org/10.1007/s40265-021-01586-y
Status	Publicerad - 2021
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

@article{b7f8fcd1ccce4ff6a1c42e061667ab4c,

title = "Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat",

keywords = "317 Pharmacy, 3121 General medicine, internal medicine and other clinical medicine",

author = "Coats, {Andrew J. S.} and Heli Tolppanen",

note = "Cited by: 1",

year = "2021",

doi = "10.1007/s40265-021-01586-y",

language = "English",

volume = "81",

pages = "1599 – 1604",

journal = "Drugs",

issn = "0012-6667",

publisher = "Adis international",

number = "14",

}

TY - JOUR

T1 - Drug Treatment of Heart Failure with Reduced Ejection Fraction: Defining the Role of Vericiguat

AU - Coats, Andrew J. S.

AU - Tolppanen, Heli

N1 - Cited by: 1

PY - 2021

Y1 - 2021

KW - 317 Pharmacy

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1007/s40265-021-01586-y

DO - 10.1007/s40265-021-01586-y

M3 - Article

SN - 0012-6667

VL - 81

SP - 1599

EP - 1604

JO - Drugs

JF - Drugs

IS - 14

ER -